ArticleCancer management and research2019

Fruquintinib: a novel antivascular endothelial growth factor receptor tyrosine kinase inhibitor for the treatment of metastatic colorectal cancer.

Ying Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.